BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lambrecht M, Melidis C, Sonke JJ, Adebahr S, Boellaard R, Verheij M, Guckenberger M, Nestle U, Hurkmans C. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective. Radiat Oncol 2016;11:7. [PMID: 26791788 DOI: 10.1186/s13014-015-0567-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Hoffmann L, Persson G, Nygård L, Nielsen T, Borrisova S, Gaard-petersen F, Josipovic M, Khalil A, Kjeldsen R, Knap M, Kristiansen C, Møller D, Ottosson W, Sand H, Thing R, Pøhl M, Schytte T. Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.04.005] [Reference Citation Analysis]
2 Vaz SC, Adam JA, Bolton RCD, Vera P, van Elmpt W, Herrmann K, Hicks RJ, Lievens Y, Santos A, Schöder H, Dubray B, Visvikis D, Troost EGC, de Geus-Oei LF. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. Eur J Nucl Med Mol Imaging 2022. [PMID: 35022844 DOI: 10.1007/s00259-021-05624-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3 Vo DT, Heinzerling JH, Timmerman RD. Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. Medical Radiology 2022. [DOI: 10.1007/174_2022_318] [Reference Citation Analysis]
4 Macmanus M, Everitt S, Hicks RJ. PET and PET/CT in Treatment Planning. Medical Radiology 2022. [DOI: 10.1007/174_2022_308] [Reference Citation Analysis]
5 Kepka L, Socha J. Dose and fractionation schedules in radiotherapy for non-small cell lung cancer. Transl Lung Cancer Res 2021;10:1969-82. [PMID: 34012807 DOI: 10.21037/tlcr-20-253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Perez-Calatayud MJ, Conde-Moreno AJ, Celada-Álvarez FJ, Rubio C, López-Campos F, Navarro-Martin A, Arribas L, Santos M, Lopez-Torrecilla J, Perez-Calatayud J. SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain. Clin Transl Oncol 2021;23:1794-800. [PMID: 33730312 DOI: 10.1007/s12094-021-02583-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Desai D, Narayanasamy G, Bimali M, Cordrey I, Elasmar H, Srinivasan S, Johnson EL. Cleaning the dose falloff in lung SBRT plan. J Appl Clin Med Phys 2021;22:100-8. [PMID: 33285036 DOI: 10.1002/acm2.13113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dimitriadis A, Tsang Y, Thomas RA, Palmer AL, Eaton D, Lee J, Patel R, Silvestre Patallo I, Gouldstone C, Snaith JA, Kirkby KJ, Nisbet A, Clark CH. Multi-institutional dosimetric delivery assessment of intracranial stereotactic radiosurgery on different treatment platforms. Radiotherapy and Oncology 2020;147:153-61. [DOI: 10.1016/j.radonc.2020.05.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhao X, Zhang R. Feasibility of 3D tracking and adaptation of VMAT based on VMAT-CT. Radiother Oncol 2020;149:18-24. [PMID: 32416375 DOI: 10.1016/j.radonc.2020.04.032] [Reference Citation Analysis]
10 Giglioli FR, Garibaldi C, Blanck O, Villaggi E, Russo S, Esposito M, Marino C, Stasi M, Mancosu P. Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives. Int J Radiat Oncol Biol Phys 2020;106:403-12. [PMID: 31707124 DOI: 10.1016/j.ijrobp.2019.10.041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
11 Kaiss H, Mornex F. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?]. Cancer Radiother 2019;23:720-31. [PMID: 31471255 DOI: 10.1016/j.canrad.2019.07.132] [Reference Citation Analysis]
12 Lambrecht ML, Eaton DJ, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW. Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial. Radiother Oncol 2019;138:106-13. [PMID: 31252291 DOI: 10.1016/j.radonc.2019.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Freedman JN, Bainbridge HE, Nill S, Collins DJ, Kachelrieß M, Leach MO, McDonald F, Oelfke U, Wetscherek A. Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems. Phys Med Biol 2019;64:115005. [PMID: 30844775 DOI: 10.1088/1361-6560/ab0dbb] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, Moustakis C, Schmitt D, Baus WW, Guckenberger M. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 2019;195:193-8. [PMID: 30649567 DOI: 10.1007/s00066-018-1416-x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 26.0] [Reference Citation Analysis]
15 Lambrecht M, Clementel E, Sonke JJ, Nestle U, Adebahr S, Guckenberger M, Andratschke N, Weber DC, Verheij M, Hurkmans CW. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results. Radiother Oncol 2019;132:63-9. [PMID: 30825971 DOI: 10.1016/j.radonc.2018.10.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lambrecht M, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW. Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours. Phys Imaging Radiat Oncol 2018;8:57-62. [PMID: 33458418 DOI: 10.1016/j.phro.2018.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
17 Murrell DH, Laba JM, Erickson A, Millman B, Palma DA, Louie AV. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk? Radiat Oncol 2018;13:57. [PMID: 29606150 DOI: 10.1186/s13014-018-1001-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
18 Clark CH, Jornet N, Muren LP. The role of dosimetry audit in achieving high quality radiotherapy. Phys Imaging Radiat Oncol 2018;5:85-7. [PMID: 33458374 DOI: 10.1016/j.phro.2018.03.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
19 Pasler M, Hernandez V, Jornet N, Clark CH. Novel methodologies for dosimetry audits: Adapting to advanced radiotherapy techniques. Phys Imaging Radiat Oncol 2018;5:76-84. [PMID: 33458373 DOI: 10.1016/j.phro.2018.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
20 Aznar MC, Warren S, Hoogeman M, Josipovic M. The impact of technology on the changing practice of lung SBRT. Phys Med 2018;47:129-38. [PMID: 29331227 DOI: 10.1016/j.ejmp.2017.12.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
21 Macmanus M, Everitt S. Treatment Planning for Radiation Therapy. PET Clinics 2018;13:43-57. [DOI: 10.1016/j.cpet.2017.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 MacManus M, Everitt S, Schimek-Jasch T, Li XA, Nestle U, Kong FS. Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization. Transl Lung Cancer Res 2017;6:670-88. [PMID: 29218270 DOI: 10.21037/tlcr.2017.09.05] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
23 Palmer AL, Nash D, Kearton JR, Jafari SM, Muscat S. A multicentre ‘end to end’ dosimetry audit of motion management (4DCT-defined motion envelope) in radiotherapy. Radiotherapy and Oncology 2017;125:453-8. [DOI: 10.1016/j.radonc.2017.09.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
24 Members of EORTC QAC., Working Groups of Scientific Experts. Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC). Eur J Cancer 2017;86:91-100. [PMID: 28964907 DOI: 10.1016/j.ejca.2017.07.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
25 Clark CH, Hurkmans CW, Kry SF; Global Quality Assurance of Radiation Therapy Clinical Trials Harmonisation Group. The role of dosimetry audit in lung SBRT multi-centre clinical trials. Phys Med 2017;44:171-6. [PMID: 28391958 DOI: 10.1016/j.ejmp.2017.04.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
26 Aznar M, Méndez Romero A, Heijmen BJ. The role of technology in clinical trials using stereotactic body radiotherapy. Br J Radiol 2017;90:20160930. [PMID: 28055252 DOI: 10.1259/bjr.20160930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Distefano G, Lee J, Jafari S, Gouldstone C, Baker C, Mayles H, Clark CH. A national dosimetry audit for stereotactic ablative radiotherapy in lung. Radiother Oncol 2017;122:406-10. [PMID: 28117079 DOI: 10.1016/j.radonc.2016.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
28 Rocco G. Narcissus, the Beam, and lung cancer. J Thorac Cardiovasc Surg 2016;152:338-343.e3. [PMID: 27209014 DOI: 10.1016/j.jtcvs.2016.04.072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]